Literature DB >> 31233138

Annual vs Biennial Screening: Diagnostic Accuracy Among Concurrent Cohorts Within the Ontario Breast Screening Program.

Anna M Chiarelli1,2, Kristina M Blackmore1, Lucia Mirea2, Susan J Done3, Vicky Majpruz1, Ashini Weerasinghe1, Linda Rabeneck1,2,4,5, Derek Muradali1,6,7.   

Abstract

BACKGROUND: The Ontario Breast Screening Program recommends annual mammography to women age 50-74 years at increased risk because of family history of breast or ovarian cancer or personal history of ovarian cancer or mammographic density 75% or greater. Few studies have examined the diagnostic accuracy of recommendations based on risk factors and included screen film as well as digital mammography.
METHODS: A retrospective design identified concurrent cohorts of women age 50-74 years screened annually or biennially with digital mammography only between 2011 and 2014 and followed until 2016 or breast cancer diagnosis. Diagnostic accuracy measures were compared between women screened annually because of first-degree relative of breast or ovarian cancer or personal history of ovarian cancer (n = 67 795 women), mammographic density 75% or greater (n = 51 956), or both (n = 3758) and those screened biennially (n = 526 815). The association between recommendation and sensitivity and specificity was assessed using generalized estimating equation models. All P values are two-sided.
RESULTS: For annual screening because of family or personal history vs biennial, sensitivity was statistically significantly higher (81.7% vs 70.6%; OR = 1.86, 95% CI = 1.48 to 2.34), particularly for invasive cancers and postmenopausal women. Although there was no statistically significant difference in sensitivity for annual screening for mammographic density 75% or greater, specificity was statistically significantly lower (91.3%; OR = 0.87, 95% CI = 0.80 to 0.96) vs biennial (92.3%), particularly for women age 50-59 years.
CONCLUSION: Compared with biennial screening, annual screening improved detection for women with a family or personal history of breast and/or ovarian cancer, supporting screening that is more frequent. The benefit for annual screening for women with higher mammographic density must be weighed against possible harms of increased false positives.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 31233138      PMCID: PMC7156935          DOI: 10.1093/jnci/djz131

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  29 in total

1.  Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.

Authors:  Rebecca A Hubbard; Karla Kerlikowske; Chris I Flowers; Bonnie C Yankaskas; Weiwei Zhu; Diana L Miglioretti
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

2.  Mammographic density and the risk and detection of breast cancer.

Authors:  Norman F Boyd; Helen Guo; Lisa J Martin; Limei Sun; Jennifer Stone; Eve Fishell; Roberta A Jong; Greg Hislop; Anna Chiarelli; Salomon Minkin; Martin J Yaffe
Journal:  N Engl J Med       Date:  2007-01-18       Impact factor: 91.245

3.  Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme.

Authors:  E Sala; R Warren; J McCann; S Duffy; N Day; R Luben
Journal:  J Med Screen       Date:  1998       Impact factor: 2.136

4.  Probabilistic linkage of large public health data files.

Authors:  M A Jaro
Journal:  Stat Med       Date:  1995 Mar 15-Apr 15       Impact factor: 2.373

5.  Biologic characteristics of interval and screen-detected breast cancers.

Authors:  F D Gilliland; N Joste; P M Stauber; W C Hunt; R Rosenberg; G Redlich; C R Key
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

6.  Diagnostic performance of digital versus film mammography for breast-cancer screening.

Authors:  Etta D Pisano; Constantine Gatsonis; Edward Hendrick; Martin Yaffe; Janet K Baum; Suddhasatta Acharyya; Emily F Conant; Laurie L Fajardo; Lawrence Bassett; Carl D'Orsi; Roberta Jong; Murray Rebner
Journal:  N Engl J Med       Date:  2005-09-16       Impact factor: 91.245

7.  Biennial versus annual mammography and the risk of late-stage breast cancer.

Authors:  Emily White; Diana L Miglioretti; Bonnie C Yankaskas; Berta M Geller; Robert D Rosenberg; Karla Kerlikowske; Laura Saba; Pamela M Vacek; Patricia A Carney; Diana S M Buist; Nina Oestreicher; William Barlow; Rachel Ballard-Barbash; Stephen H Taplin
Journal:  J Natl Cancer Inst       Date:  2004-12-15       Impact factor: 13.506

8.  Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.

Authors:  Karla Kerlikowske; Weiwei Zhu; Rebecca A Hubbard; Berta Geller; Kim Dittus; Dejana Braithwaite; Karen J Wernli; Diana L Miglioretti; Ellen S O'Meara
Journal:  JAMA Intern Med       Date:  2013-05-13       Impact factor: 21.873

9.  Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England.

Authors:  S Sutton; G Saidi; G Bickler; J Hunter
Journal:  J Epidemiol Community Health       Date:  1995-08       Impact factor: 3.710

10.  Comparison of 1- and 2-year screening intervals for women undergoing screening mammography.

Authors:  E S Wai; Y D'yachkova; I A Olivotto; S Tyldesley; N Phillips; L J Warren; A J Coldman
Journal:  Br J Cancer       Date:  2005-03-14       Impact factor: 7.640

View more
  2 in total

1.  Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive study.

Authors:  Anna M Chiarelli; Meghan J Walker; Gabriela Espino-Hernandez; Natasha Gray; Ayesha Salleh; Chamila Adhihetty; Julia Gao; Samantha Fienberg; Michelle A Rey; Linda Rabeneck
Journal:  CMAJ Open       Date:  2021-12-21

2.  Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study.

Authors:  Steven Habbous; Esha Homenauth; Andriana Barisic; Sharmilaa Kandasamy; Vicky Majpruz; Katharina Forster; Marta Yurcan; Anna M Chiarelli; Patti Groome; Claire M B Holloway; Andrea Eisen
Journal:  CMAJ Open       Date:  2022-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.